PATENT CLAIM ANALYSIS

Application Number: 16161413
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-08
Patent Classification: ["514", "443000"]

Abstract:
The present invention relates to a novel naphtho class of compounds as Stat3 pathway inhibitors and as cancer stem cell inhibitors; to methods of using such compounds to treat cancer; to methods of using such compounds to treat disorders in a mammal related to aberrent Stat3 pathway activity; to pharmaceutical compositions containing such compounds.

Claim (Index 7):
The method of  claim 6 , wherein the cancer is selected from the group consisting of breast cancer, head and neck cancer, lung cancer, ovarian cancer, pancreatic cancer, multiple myeloma, colorectal carcinoma, prostate cancer, melanoma, kaposi sarcoma, ewing's sarcoma, liver cancer, gastric cancer, medulloblastoma, brain tumors, leukemia.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.70588
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14499299', '12677511', '14445783', '14208170', '15987525']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8471226185404186
- 35 USC 102 Novelty (BERT): 0.5809623981410309
- Combined Prediction Score: 0.8205065965004799
- Mean Citation Score: 432.10478600000016
- Max Citation Score: 550.5484
- Similarity Product: 389.86433529322153

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test